Quest Laboratories Limited (NSE:QUESTLAB)

India flag India · Delayed Price · Currency is INR
96.20
-9.75 (-9.20%)
Jan 23, 2026, 3:27 PM IST
-35.72%
Market Cap1.58B
Revenue (ttm)1.10B
Net Income (ttm)142.10M
Shares Out16.39M
EPS (ttm)8.68
PE Ratio11.09
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,000
Average Volume22,080
Open104.00
Previous Close105.95
Day's Range90.50 - 104.00
52-Week Range75.15 - 160.00
Betan/a
RSI45.46
Earnings DateFeb 12, 2026

About Quest Laboratories

Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufa... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 50
Stock Exchange National Stock Exchange of India
Ticker Symbol QUESTLAB
Full Company Profile

Financial Performance

In 2024, Quest Laboratories's revenue was 1.04 billion, an increase of 25.92% compared to the previous year's 825.63 million. Earnings were 135.66 million, an increase of 34.40%.

Financial Statements